In what's becoming a daily update on the state of drug advertising, today the Los Angeles Times reviews the following:
- Congressional investigations of ads for the newly controversial med Vytorin, made by Merck and Schering-Plough, and the non-rowing, non-practicing doctor-slash-pitchman for Pfizer's Lipitor.
- A program that would have stepped up FDA oversight for such ads was scuttled last month for lack of funding.
- A Consumer Reports feature called AdWatch is stepping into the breach, reviewing info included--and neglected--of national ads. Its first subject: the restless-legs syndrome med Requip.
We were just as interested, though, in which drug websites are most popular with doctors, a list published by the Chicago Tribune. Here are the top five:
- Adderal XR
The rest of the top 10, plus the 2006 list, are available at the link below. Hint: They include two of the biggest newsmakers of recent months.